Related Experiment Videos
Expression of mRNA for RANTES in human eosinophils
J Chihara1, H Oyamada, H Yamada
1Department of Clinical and Laboratory Medicine, Akita University School of Medicine, Hondo, Japan.
International Archives of Allergy and Immunology
|November 18, 1997
Summary
Eosinophils from asthma patients express and release RANTES, a key inflammatory mediator. This suggests eosinophils are crucial in recruiting immune cells to inflamed airways in asthma.
Area of Science:
- Immunology
- Allergy Research
- Respiratory Medicine
Background:
- RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) is a potent chemoattractant for inflammatory cells like eosinophils.
- Eosinophils are key inflammatory cells in bronchial asthma, causing damage to airway tissues.
- Eosinophils can synthesize cytokines, including IL-5, influencing their own regulation.
Purpose of the Study:
- To investigate the expression of mRNA for RANTES in human eosinophils.
- To determine the release of RANTES by human eosinophils.
Main Methods:
- Isolation of eosinophils from asthmatic patients.
- Analysis of RANTES mRNA expression.
- Measurement of RANTES release.
Main Results:
- Eosinophils from asthmatic patients demonstrated expression of RANTES mRNA.
- These eosinophils were found to release RANTES.
- The study confirmed RANTES production by human eosinophils.
Conclusions:
- Eosinophils play a significant role in asthma pathogenesis.
- Eosinophil-derived RANTES contributes to the recruitment of eosinophils and T lymphocytes to inflamed sites in asthma.
- This highlights a potential therapeutic target in asthma management.